Sensory Attenuation in Parkinson’s Disease Is Related to Disease Severity and Dopamine Dose

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-33678-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

It Is Dopey to Stop Giving Dopamine to Hospitalized Patients With Parkinson’s Disease

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2017English

Dopamine Agonists and Impulse Control Disorders in Parkinson’s Disease

US Neurology
NeuroscienceNeurology
2013English

Parkinson’s Disease, Dopamine, and Eating and Weight Disorders: An Illness in the Disease?

Eating and Weight Disorders
PsychiatryClinical PsychologyMental Health
2019English

Event-Related Potentials in Parkinson’s Disease

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2015English

Movement-Related Potentials in Parkinson’s Disease

Clinical Neurophysiology
Sensory SystemsNeurologyPhysiology
2016English

Parkinson’s Disease and Dopamine Transporter Neuroimaging: A Critical Review

Sao Paulo Medical Journal
Medicine
2006English

Pentraxin-3 Is Not Related to Disease Severity in Cirrhosis and Hepatocellular Carcinoma Patients

Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Nonmotor Outcomes in Parkinson’s Disease: Is Deep Brain Stimulation Better Than Dopamine Replacement Therapy?

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2011English

Replacing Dopamine Neurons in Parkinson’s Disease: How Did It Happen?

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy